Table 1. The Prevalence of OBI and HBV Serological Markers Among Blood Recipient Patients.
| Disease | Country | Region, City | Prevalence of OBI a, % | Prevalence, % | |||
| Anti HBc | Anti HBs | HBs Ag | |||||
| Toyoda et al. [11] (2004) | Hemophilia | Japan | ND | 51.2 | 86 | 62.8 | 0 |
| Borhany et al. [12] (2011) | Hemophilia | Pakistan | Karachi | 1.73 | ND a | ND | ND |
| Windyga et al. [13] (2006) | Hemophilia | Polish | ND | 0 | 69.5 | 49.5 | 7.8 |
| Aghakhani et al. [18] (2010) | Hemodialysis | Iran | Tehran | 3.11 | 6.2 | 77.5 | 2.8 |
| Arababadi et al. [2] (2009) | Hemodialysis | Iran | Kerman | 0 | 33.3 | 40.7 | 0 |
| Di Stefano et al. [20] (2009) | Hemodialysis | Italia | ND | 26.6 | 72 | 31 | ND |
| Abu-El-Makarem et al. [22] (2012) | Hemodialysis | Egypt | ND | 4.13 | 20 | ND | ND |
| Sav et al. [25] (2010) | Hemodialysis | Turkey | ND | 16.9 | ND | ND | ND |
| Kanbay et al. [24] (2006) | Hemodialysis | Turkey | ND | 15.2 | ND | ND | ND |
| Goral et al. [28] (2006) | Hemodialysis | Turkey | ND | 0 | ND | ND | 0 |
| Siagris et al. and Mina et al. [10][29] (2010) | Hemodialysis | Greece | ND | 0.9-20.4 | 47.8 | 66.9 | 5.5 |
| Motta et al. [31] (2010) | Hemodialysis | Brasilia | ND | 15 | 3 | 27 | 0 |
| Gabrerizo et al. [30] (1997) | Hemodialysis | Italy | ND | 58 | ND | ND | ND |
| Gwak et al. [32] (2008) | Hemodialysis | South-Korea | ND | 0 | 67.4 | 69.8 | 4.8 |
| Jain et al. [23] (2008) | Hemodialysis | China | ND | 5 | 5 | ND | 11 |
| Singh et al. [17] (2003) | Thalassemia | India | ND | 31.4 | 20 | 75.7 | 5.7 |
| Arababadi et al. [14] (2008) | Thalassemia | Iran | Kerman | 0 | 33 | 40.7 | 0 |
a Abbreviations: ND, not determinant; OBI, occult hepatitis B infection